SB 271046 hydrochloride is a selective 5-HT6 receptor antagonist with potential therapeutic applications in cognitive and memory disorders; it demonstrates anticonvulsant activity by increasing seizure threshold in rodent models; it enhances extracellular levels of glutamate and aspartate in the prefrontal cortex and hippocampus, which may underlie its procognitive effects; it effectively reverses scopolamine-induced amnesia in rats, supporting its use as a cognitive enhancer.